USD 12.24
| ticker | 1 day return % | 1 week return % | 1 month return % | 3 months return % | 6 months return % | 1 year return % | 3 years return % | 5 years return % | 10 years return % | maximum return % |
|---|---|---|---|---|---|---|---|---|---|---|
| ASC | -2.3 | -10.9 | 7.5 | -27.0 | -39.5 | -21.0 | 251.7 | 69.8 | 12.3 | -9.3 |
| S&P 500 | 1.0 | 3.7 | 2.1 | 2.3 | 8.2 | 25.4 | 31.0 | 80.6 | 196.5 | 33856.2 |
Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline
Feel free to experiment with these tools to enhance your technical analysis. Remember, any drawings you make are temporary and will be lost upon refreshing the page unless saved as an image using the 'Camera' icon.
Get instant AI-powered professional insights on prices:
💡Generate AI Technical Analysis ReportA Multi-Interval Candlestick Chart displays the price movements of an asset over different time intervals. Each candlestick represents the open, high, low, and close prices for a specific interval. The chart can be used to identify trends and patterns in price movements.
| Attribute | Value |
|---|---|
| symbol | ASC |
| name | Ardmore Shipping Corporation |
| price | 12.24 |
| changes percentage | -2.3144 |
| change | -0.29 |
| day low | 12.14 |
| day high | 12.61 |
| year high | 23.44 |
| year low | 10.86 |
| market cap | 512142408 |
| price avg 50 | 12.0526 |
| price avg 200 | 17.28575 |
| exchange | NYSE |
| volume | 601032 |
| avg volume | 892129 |
| open | 12.42 |
| previous close | 12.53 |
| eps | 3.55 |
| pe | 3.45 |
| earnings announcement | 2025-02-18T12:00:00.000+0000 |
| shares outstanding | 41841700 |
| timestamp | 2025-01-17 21:00:02 |
We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001577437 | |||
| revenue | 395978000 | 445741000 | -11.16 |
| gross profit | 153371000 | 195531000 | -21.56 |
| gross profit ratio | 0.39 | 0.44 | -11.70 |
| research and development expenses | 0 | 0 | NaN |
| operating expenses | 25241000 | 36077000 | -30.04 |
| interest income | 1818000 | 471000 | 285.99 |
| interest expense | 11408000 | 15537000 | -26.58 |
| ebitda | 157846000 | 187830000 | -15.96 |
| ebitdaratio | 0.4 | 0.42 | -6.09 |
| operating income | 155947000 | 159925000 | -2.49 |
| operating income ratio | 0.39 | 0.36 | 9.77 |
| net income | 116808000 | 138454000 | -15.63 |
| net income ratio | 0.29 | 0.31 | -5.03 |
| eps | 2.76 | 3.63 | -23.97 |
Revenue Growth: revenue decreased to 396 million in 2023 from 446 million in 2022 representing a change of -11.16%. This indicates a sales shrinking, which is a negative sign for the company.
Gross Profit: Gross Profit decreased to 153 million in 2023 from 196 million in 2022 representing a change of -21.56%. This indicates a sales profitability decline, which is a negative sign for the company.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 158 million in 2023 from 188 million in 2022 representing a change of -15.96%. The decrease in EBITDA indicates declined operational efficiency and profitability.
Operating Income: Operating income decreased to 156 million in 2023 from 160 million in 2022 representing a change of -2.49%. The decrease in operating income indicates worse operational performance and decreased profitability.
Net Income: Net income decreased to 117 million in 2023 from 138 million in 2022 representing a change of -15.63%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.
Earnings per Share (EPS): EPS increased to 2.76 in 2023 from 2.76 in 2022 representing a change of -23.97%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.
Operating Expenses: Operating Expenses decreased to 25 million in 2023 from 36 million in 2022 representing a change of -30.04%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001577437 | |||
| revenue | 96118000 | 121325000 | -20.78 |
| gross profit | 36906000 | 56279000 | -34.42 |
| gross profit ratio | 0.38 | 0.46 | -17.23 |
| research and development expenses | 0 | 0 | NaN |
| operating expenses | 36906000 | 6328000 | 483.22 |
| interest income | 226000 | 612000 | -63.07 |
| interest expense | 1103000 | 2044000 | -46.04 |
| ebitda | 33374000 | 58495000 | -42.95 |
| ebitdaratio | 0.35 | 0.48 | -27.98 |
| operating income | 0 | 57556000 | -100.00 |
| operating income ratio | 0 | 0.47 | -100.00 |
| net income | 24144000 | 62692000 | -61.49 |
| net income ratio | 0.25 | 0.52 | -51.39 |
| eps | 0.55 | 1.48 | -62.84 |
Revenue Growth: revenue increased to 96 million in 2024Q3 from 121 million in 2024Q2 representing a change of -20.78%. This indicates a sales growth, which is a positive sign for the company.
Operating Expenses: Operating Expenses decreased to 37 million in 2024Q3 from 6 million in 2024Q2 representing a change of 483.22%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.
Gross Profit: Gross Profit decreased to 37 million in 2024Q3 from 56 million in 2024Q2 representing a change of -34.42%. This indicates a sales profitability decline, which is a negative sign for the company.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 33 million in 2024Q3 from 58 million in 2024Q2 representing a change of -42.95%. The decrease in EBITDA indicates declined operational efficiency and profitability.
Operating Income: Operating income decreased to 0 million in 2024Q3 from 58 million in 2024Q2 representing a change of -100.0%. The decrease in operating income indicates worse operational performance and decreased profitability.
Net Income: Net income decreased to 24 million in 2024Q3 from 63 million in 2024Q2 representing a change of -61.49%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.
Earnings per Share (EPS): EPS increased to 0.55 in 2024Q3 from 0.55 in 2024Q2 representing a change of -62.84%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001577437 | |||
| total assets | 690951000 | 723859000 | -4.55 |
| total liabilities | 116507000 | 217417000 | -46.41 |
| total equity | 574444000 | 506442000 | 13.43 |
| cash and cash equivalents | 46805000 | 50569000 | -7.44 |
| short term investments | 0 | 4927000 | -100.00 |
| long term investments | 10700000 | 11219000 | -4.63 |
| total current assets | 126778000 | 157738000 | -19.63 |
| total non current assets | 564173000 | 566121000 | -0.34 |
| total current liabilities | 33839000 | 52929000 | -36.07 |
| total non current liabilities | 82668000 | 164488000 | -49.74 |
| common stock | 433000 | 426000 | 1.64 |
| retained earnings | 81388000 | 15135000 | 437.75 |
| total debt | 93986000 | 184623000 | -49.09 |
Total Assets: Total Assets decreased to 691 million in 2023 from 724 million in 2022 representing a change of -4.55%. Suggesting a decrease in asset holdings.
Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 47 million in 2023 from 51 million in 2022 representing a change of -7.44%. This indicates a decrease in available liquid assets.
Short Term Investments: Short Term Investments decreased to 0 million in 2023 from 5 million in 2022 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.
Total Current Assets: Total Current Assets decreased to 127 million in 2023 from 158 million in 2022 representing a change of -19.63%. This indicates a worsen liquidity position.
Total Liabilities: Total Liabilities decreased to 117 million in 2023 from 217 million in 2022 representing a change of -46.41%. This indicates a decrease in overall liabilities.
Total Equity: Total Equity increased to 574 million in 2023 from 506 million in 2022 representing a change of 13.43%. This indicates an increase in shareholders' equity.
Total Current Liabilities: Total Current Liabilities decreased to 34 million in 2023 from 53 million in 2022 representing a change of -36.07%. This indicates a lower short-term debt burden.
Common Stock: Common Stock increased to 0 in 2023 from 0 in 2022 representing a change of 1.64%. This indicates an increase in ownership interest.
Retained Earnings: Retained Earnings increased to 81 million in 2023 from 15 million in 2022 representing a change of 437.75%. This indicates an accumulated profits.
Total Debt: Total Debt decreased to 94 million in 2023 from 185 million in 2022 representing a change of -49.09%. This indicates a reduction in overall debt burden.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001577437 | |||
| total assets | 722813000 | 742030000 | -2.59 |
| total liabilities | 58772000 | 87272000 | -32.66 |
| total equity | 664041000 | 654758000 | 1.42 |
| cash and cash equivalents | 47574000 | 47396000 | 0.38 |
| short term investments | 0 | 0 | NaN |
| long term investments | 0 | 9200000 | -100.00 |
| total current assets | 132763000 | 142377000 | -6.75 |
| total non current assets | 590050000 | 599653000 | -1.60 |
| total current liabilities | 37183000 | 40680000 | -8.60 |
| total non current liabilities | 21589000 | 46592000 | -53.66 |
| common stock | 440000 | 439000 | 0.23 |
| retained earnings | 167389000 | 160002000 | 4.62 |
| total debt | 30012000 | 53525000 | -43.93 |
Total Assets: Total Assets decreased to 723 million in 2024Q3 from 742 million in 2024Q2 representing a change of -2.59%. Suggesting a decrease in asset holdings.
Total Current Assets: Total Current Assets decreased to 133 million in 2024Q3 from 142 million in 2024Q2 representing a change of -6.75%. This indicates a worsen liquidity position.
Total Liabilities: Total Liabilities decreased to 59 million in 2024Q3 from 87 million in 2024Q2 representing a change of -32.66%. This indicates a decrease in overall liabilities.
Total Equity: Total Equity increased to 664 million in 2024Q3 from 655 million in 2024Q2 representing a change of 1.42%. This indicates an increase in shareholders' equity.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 48 million in 2024Q3 from 47 million in 2024Q2 representing a change of 0.38%. This indicates an increase in available liquid assets.
Total Current Liabilities: Total Current Liabilities decreased to 37 million in 2024Q3 from 41 million in 2024Q2 representing a change of -8.6%. This indicates a lower short-term debt burden.
Common Stock: Common Stock increased to 0 in 2024Q3 from 0 in 2024Q2 representing a change of 0.23%. This indicates an increase in ownership interest.
Retained Earnings: Retained Earnings increased to 167 million in 2024Q3 from 160 million in 2024Q2 representing a change of 4.62%. This indicates an accumulated profits.
Total Debt: Total Debt decreased to 30 million in 2024Q3 from 54 million in 2024Q2 representing a change of -43.93%. This indicates a reduction in overall debt burden.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001577437 | |||
| net change in cash | -3764000 | -4880000 | 22.87 |
| operating cash flow | 159609000 | 124207000 | 28.50 |
| free cash flow | 134225000 | 120399000 | 11.48 |
| capital expenditure | -25384000 | -3808000 | -566.60 |
| depreciation and amortization | 31359000 | 29276000 | 7.12 |
| deferred income tax | 0 | 0 | NaN |
| stock based compensation | 3217000 | 3057000 | 5.23 |
| accounts payables | -4410000 | -1612000 | -173.57 |
| inventory | 3160000 | -4623000 | 168.35 |
| acquisitions net | -1244000 | -588000 | -111.56 |
| investments in property plant and equipment | -25384000 | -3808000 | -566.60 |
| net cash used for investing activites | -26836000 | 35410000 | -175.79 |
| debt repayment | -85983000 | -196616000 | 56.27 |
| common stock issued | 0 | 38909000 | -100.00 |
| common stock repurchased | 0 | 0 | NaN |
| dividends paid | -50554000 | -3285000 | -1438.93 |
| net cash used provided by financing activities | -136537000 | -164497000 | 17.00 |
| cash at end of period | 46805000 | 50569000 | -7.44 |
| accounts receivables | 23610000 | -59559000 | 139.64 |
| cash at beginning of period | 50569000 | 55449000 | -8.80 |
Net Change in Cash: Net Change in Cash increased to -4 million in 2023 from -5 million in 2022 representing a change of 22.87%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow increased to 160 million in 2023 from 124 million in 2022 representing a change of 28.5%. This indicates that the company generated more cash from its core business operations.
Free Cash Flow: Free Cash Flow increased to 134 million in 2023 from 120 million in 2022 representing a change of 11.48%. This indicates an increase in cash generated after accounting for capital expenditures.
Capital Expenditure: Capital Expenditure decreased to -25 million in 2023 from -4 million in 2022 representing a change of -566.6%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.
Stock-Based Compensation: Stock-Based Compensation increased to 3 million in 2023 from 3 million in 2022 representing a change of 5.23%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.
Accounts Payables: The absolute value of Accounts Payables increased to 4 million in 2023 from 2 million in 2022 representing a change of -173.57%. This indicates that the company has increased its outstanding obligations to its suppliers.
Accounts Receivables: Accounts Receivables increased to 24 in 2023 from -60 million in 2022 representing a change of 139.64%. This suggests that the company is less capable of collecting payments from its customers.
Dividends Paid: Dividends Paid decreased to -51 million in 2023 from -3 million in 2022 representing a change of -1438.93%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001577437 | |||
| operating cash flow | 39880000 | 48020746 | -16.95 |
| free cash flow | 38618000 | 4634823 | 733.21 |
| capital expenditure | -1262000 | -43385923 | 97.09 |
| depreciation and amortization | 7833000 | 7606000 | 2.98 |
| deferred income tax | 0 | 0 | NaN |
| stock based compensation | 1897000 | 873000 | 117.30 |
| accounts receivables | 10090000 | -14749314 | 168.41 |
| accounts payables | -4668000 | 6852422 | -168.12 |
| inventory | 1633000 | -1271401 | 228.44 |
| acquisitions net | 0 | 1650000 | -100.00 |
| investments in property plant and equipment | -1262000 | -43578000 | 97.10 |
| net cash used for investing activites | -1297000 | -15135000 | 91.43 |
| debt repayment | -21659000 | -20651485 | -4.88 |
| common stock issued | 0 | 0 | NaN |
| common stock repurchased | 0 | 0 | NaN |
| dividends paid | -16746000 | -13698779 | -22.24 |
| net cash used provided by financing activities | -38405000 | -34503000 | -11.31 |
| net change in cash | 178000 | -1228000 | 114.50 |
| cash at end of period | 47574000 | 47396000 | 0.38 |
| cash at beginning of period | 47396000 | 48624000 | -2.53 |
Net Change in Cash: Net Change in Cash increased to 0 million in 2024Q3 from -1 million in 2024Q2 representing a change of 114.5%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Free Cash Flow: Free Cash Flow increased to 39 million in 2024Q3 from 5 million in 2024Q2 representing a change of 733.21%. This indicates an increase in cash generated after accounting for capital expenditures.
Accounts Payables: The absolute value of Accounts Payables decreased to 5 million in 2024Q3 from 7 million in 2024Q2 representing a change of -168.12%. This indicates that the company has reduced its outstanding obligations to its suppliers.
Operating Cash Flow: Operating Cash Flow decreased to 40 million in 2024Q3 from 48 million in 2024Q2 representing a change of -16.95%. This indicates that the company generated less cash from its core business operations.
Capital Expenditure: Capital Expenditure increased to -1 million in 2024Q3 from -43 million in 2024Q2 representing a change of 97.09%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.
Stock-Based Compensation: Stock-Based Compensation increased to 2 million in 2024Q3 from 1 million in 2024Q2 representing a change of 117.3%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.
Accounts Receivables: Accounts Receivables increased to 10 in 2024Q3 from -15 million in 2024Q2 representing a change of 168.41%. This suggests that the company is less capable of collecting payments from its customers.
Dividends Paid: Dividends Paid decreased to -17 million in 2024Q3 from -14 million in 2024Q2 representing a change of -22.24%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.
We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.
Note: The years mentioned below are fiscal years in accounting.
Q3 2024 Earnings call transcript
EPS represents the portion of a company's profit allocated to each outstanding share of common stock. A higher EPS is generally favorable, indicating stronger profitability on a per-share basis.
Positive EPS: A positive EPS signifies that a company is profitable, it is generally viewed positively, supporting stock value and investor confidence.
Negative EPS: Indicates that a company is operating at a loss, which could lead to negative sentiment, potential stock depreciation, and concerns about the company's financial health.
The Next Earning Date represents when the company plans to release its next set of financial results.
An upward trend in EPS suggests consistent growth in earnings, often leading to increased investor confidence. A downward trend may indicate a decline in earnings, potentially decreasing investor confidence and stock value. Fluctuating EPS suggests unpredictable financial performance, warranting cautious investor analysis.
Earnings surprise occurs when a company's actual earnings differ from analysts' expectations. A positive earnings surprise typically reflects better-than-expected performance, potentially leading to stock appreciation. Conversely, a negative earnings surprise can result in stock depreciation. An earnings surprise of zero means the earnings met expectations, which typically has a neutral impact on stock price.
Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.
| 2023-12-31 | 2022-12-31 | Y/Y change % | |
|---|---|---|---|
| FY | |||
| calendar year | 2023 | 2022 | NaN |
| revenue per share | 9.63 | 11.97 | -19.58 |
| net income per share | 2.84 | 3.72 | -23.62 |
| operating cash flow per share | 3.88 | 3.34 | 16.33 |
| free cash flow per share | 3.26 | 3.23 | 0.93 |
| cash per share | 1.14 | 1.49 | -23.65 |
| book value per share | 13.97 | 13.6 | 2.69 |
| tangible book value per share | 13.97 | 13.6 | 2.69 |
| shareholders equity per share | 13.97 | 13.6 | 2.69 |
| interest debt per share | 2.56 | 5.38 | -52.33 |
| market cap | 588160272.7 | 536564981.59 | 9.62 |
| enterprise value | 635341272.7 | 670618981.59 | -5.26 |
| pe ratio | 5.04 | 3.88 | 29.93 |
| price to sales ratio | 1.49 | 1.2 | 23.39 |
| pocfratio | 3.69 | 4.32 | -14.70 |
| pfcf ratio | 4.38 | 4.46 | -1.68 |
| pb ratio | 1.02 | 1.06 | -3.36 |
| ptb ratio | 1.02 | 1.06 | -3.36 |
| ev to sales | 1.6 | 1.5 | 6.65 |
| enterprise value over ebitda | 4.03 | 3.57 | 12.74 |
| ev to operating cash flow | 3.98 | 5.4 | -26.27 |
| ev to free cash flow | 4.73 | 5.57 | -15.02 |
| earnings yield | 0.2 | 0.26 | -23.03 |
| free cash flow yield | 0.23 | 0.22 | 1.70 |
| debt to equity | 0.16 | 0.36 | -55.12 |
| debt to assets | 0.14 | 0.26 | -46.67 |
| net debt to ebitda | 0.3 | 0.71 | -58.12 |
| current ratio | 3.75 | 2.98 | 25.71 |
| interest coverage | 13.67 | 10.29 | 32.81 |
| income quality | 1.37 | 0.9 | 52.32 |
| dividend yield | 0.09 | 0.01 | 1303.93 |
| payout ratio | 0.43 | 0.02 | 1724.12 |
| sales general and administrative to revenue | 0.05 | 0.05 | -3.97 |
| research and ddevelopement to revenue | 0 | 0 | NaN |
| intangibles to total assets | 0 | 0 | NaN |
| capex to operating cash flow | 0.16 | 0.03 | 418.74 |
| capex to revenue | 0.06 | 0.01 | 650.37 |
| capex to depreciation | 0.81 | 0.13 | 522.32 |
| stock based compensation to revenue | 0.01 | 0.01 | 18.46 |
| graham number | 29.87 | 33.73 | -11.44 |
| roic | 0.23 | 0.23 | 0.60 |
| return on tangible assets | 0.17 | 0.19 | -11.62 |
| graham net net | -0.52 | -2.53 | 79.58 |
| working capital | 92939000 | 104809000 | -11.33 |
| tangible asset value | 574444000 | 506442000 | 13.43 |
| net current asset value | 10271000 | -59679000 | 117.21 |
| invested capital | 631069000 | 652278000 | -3.25 |
| average receivables | 68038500 | 50073500 | 35.88 |
| average payables | 5415000 | 8696000 | -37.73 |
| average inventory | 14138000 | 13406659 | 5.46 |
| days sales outstanding | 51.83 | 65.38 | -20.72 |
| days payables outstanding | 3.03 | 12.86 | -76.41 |
| days of inventory on hand | 18.89 | 22.93 | -17.60 |
| receivables turnover | 7.04 | 5.58 | 26.13 |
| payables turnover | 120.34 | 28.39 | 323.92 |
| inventory turnover | 19.32 | 15.92 | 21.36 |
| roe | 0.2 | 0.27 | -25.62 |
| capex per share | 0.62 | 0.1 | 503.48 |
ROE: Return on Equity (ROE) decreased to 0.20 on 2023-12-31 from 0.27 on 2022-12-31, representing a change of -25.62%. However, ROE is >= 15%, suggesting that the company has been generating high returns for its shareholders still.
PE Ratio: Price-to-Earnings (P/E) Ratio increased to 5.04 on 2023-12-31 from 3.88 on 2022-12-31, representing a change of 29.93%. Indicating an increase in the relative valuation of the company's stock.
Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.16 on 2023-12-31 from 0.36 on 2022-12-31, representing a change of -55.12%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
Current Ratio: Current Ratio increased to 3.75 on 2023-12-31 from 2.98 on 2022-12-31, representing a change of 25.71%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.
| 2024-09-30 Q3 | 2024-06-30 Q2 | Q/Q change % | |
|---|---|---|---|
| ASC | |||
| calendar year | 2024 | 2024 | NaN |
| revenue per share | 2.28 | 2.91 | -21.50 |
| net income per share | 0.57 | 1.5 | -61.84 |
| operating cash flow per share | 0.95 | 1.15 | -17.72 |
| free cash flow per share | 0.92 | 0.11 | 725.56 |
| cash per share | 1.13 | 1.14 | -0.55 |
| book value per share | 15.76 | 15.68 | 0.49 |
| tangible book value per share | 15.76 | 15.68 | 0.49 |
| shareholders equity per share | 15.76 | 15.68 | 0.49 |
| interest debt per share | 0.74 | 1.33 | -44.52 |
| market cap | 762646486.5 | 931814846.64 | -18.15 |
| enterprise value | 745084486.5 | 937943846.64 | -20.56 |
| pe ratio | 7.9 | 3.72 | 112.52 |
| price to sales ratio | 7.93 | 7.68 | 3.31 |
| pocfratio | 19.12 | 19.4 | -1.45 |
| pfcf ratio | 19.75 | 201.05 | -90.18 |
| pb ratio | 1.15 | 1.42 | -19.30 |
| ptb ratio | 1.15 | 1.42 | -19.30 |
| ev to sales | 7.75 | 7.73 | 0.27 |
| enterprise value over ebitda | 22.33 | 16.03 | 39.23 |
| ev to operating cash flow | 18.68 | 19.53 | -4.35 |
| ev to free cash flow | 19.29 | 202.37 | -90.47 |
| earnings yield | 0.03 | 0.07 | -52.95 |
| free cash flow yield | 0.05 | 0.0 | 918.04 |
| debt to equity | 0.05 | 0.08 | -44.71 |
| debt to assets | 0.04 | 0.07 | -42.44 |
| net debt to ebitda | -0.53 | 0.1 | -602.22 |
| current ratio | 3.57 | 3.5 | 2.02 |
| interest coverage | 0 | 28.16 | -100.00 |
| income quality | 1.65 | 0.77 | 115.65 |
| dividend yield | 0.02 | 0.01 | 49.36 |
| payout ratio | 0.69 | 0.22 | 217.42 |
| sales general and administrative to revenue | 0.08 | 0.05 | 49.32 |
| research and ddevelopement to revenue | 0 | 0 | NaN |
| intangibles to total assets | 0 | 0 | NaN |
| capex to operating cash flow | 0.03 | 0.9 | -96.50 |
| capex to revenue | 0.01 | 0.36 | -96.33 |
| capex to depreciation | 0.16 | 5.7 | -97.18 |
| stock based compensation to revenue | 0.02 | 0.01 | 174.28 |
| graham number | 14.25 | 23.02 | -38.08 |
| roic | 0 | 0.08 | -100.00 |
| return on tangible assets | 0.03 | 0.08 | -60.46 |
| graham net net | 1.03 | 0.55 | 86.11 |
| working capital | 95580000 | 101697000 | -6.01 |
| tangible asset value | 664041000 | 654758000 | 1.42 |
| net current asset value | 73991000 | 55105000 | 34.27 |
| invested capital | 658425000 | 672990000 | -2.16 |
| average receivables | 70123500 | 67755500 | 3.49 |
| average payables | 10326500 | 9807000 | 5.30 |
| average inventory | 12391000 | 12571000 | -1.43 |
| days sales outstanding | 60.94 | 55.76 | 9.28 |
| days payables outstanding | 11.02 | 18.54 | -40.57 |
| days of inventory on hand | 17.59 | 18.28 | -3.74 |
| receivables turnover | 1.48 | 1.61 | -8.49 |
| payables turnover | 8.17 | 4.85 | 68.25 |
| inventory turnover | 5.12 | 4.92 | 3.88 |
| roe | 0.04 | 0.1 | -62.03 |
| capex per share | 0.03 | 1.04 | -97.12 |
ROE: Return on Equity (ROE) decreased to 0.04 on 2024-09-30 Q3 from 0.10 on 2024-06-30 Q2, representing a change of -62.03%. Suggesting that the company has not been generating high returns for its shareholders.
Current Ratio: Current Ratio increased to 3.57 on 2024-09-30 Q3 from 3.50 on 2024-06-30 Q2, representing a change of 2.02%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.
PE Ratio: Price-to-Earnings (P/E) Ratio increased to 7.90 on 2024-09-30 Q3 from 3.72 on 2024-06-30 Q2, representing a change of 112.52%. Indicating an increase in the relative valuation of the company's stock.
Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.05 on 2024-09-30 Q3 from 0.08 on 2024-06-30 Q2, representing a change of -44.71%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
Positive Sentiment: Discounted Cash Flow value is 26.82 which is higher than current price 12.24, indicates the company may be undervalued.
| Market Capitalization | Enterprise Value | |
|---|---|---|
| Definition | The total market value of a company's outstanding shares | The total market value of a company, including its debt and other liabilities |
| Calculation | Current share price * Total number of outstanding shares | Market capitalization + Total debt - Cash and cash equivalents |
| Focus | Equity component of a company's value | Total economic value of a company |
| Usefulness | Assesses a company's size and growth potential based on investor sentiment | Provides a more comprehensive valuation that considers both equity and debt |
Analyzing dividends is a crucial aspect of investment evaluation, offering valuable insights into a company's financial health and its commitment to shareholder returns. Dividends represent a portion of a company's profits distributed to its shareholders, providing a steady income stream. We help you analyze dividends based on the indicators mentioned below:
• Investors often assess the average dividend amount, observing trends over time to gauge the company's stability and growth potential. A positive trend in average dividends indicates a consistent and potentially lucrative investment. Additionally, evaluating the trend of dividend increases provides insight into the company's financial strength and management's confidence in future earnings.
• Consistency in paying dividends is a reassuring sign, reflecting a company's reliability and commitment to shareholder value. For investors, dividends not only offer income but also contribute to the overall total return on investment.
• Companies with a history of regular and increasing dividends can attract income-focused investors seeking stable returns, making dividends a critical factor in building a well-rounded investment portfolio.
Interested in the overall sentiment for a particular period? Check out our news sentiment analysis tool.
Sentiment: Neutral
Publish Date: 2025-01-15 18:55:35
Ardmore Shipping (ASC) concluded the recent trading session at $13.23, signifying a +1.22% move from its prior day's close.
Sentiment: Negative
Publish Date: 2025-01-09 18:55:25
In the most recent trading session, Ardmore Shipping (ASC) closed at $12.56, indicating a -1.64% shift from the previous trading day.
Sentiment: Positive
Publish Date: 2025-01-07 10:16:53
Zacks.com users have recently been watching Ardmore Shipping (ASC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Sentiment: Positive
Publish Date: 2025-01-03 19:12:09
In the closing of the recent trading day, Ardmore Shipping (ASC) stood at $12.34, denoting a -0.72% change from the preceding trading day.
Sentiment: Positive
Publish Date: 2025-01-03 10:46:36
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Sentiment: Positive
Publish Date: 2025-01-02 06:56:09
AGCO, AMPH and ASC have been added to the Zacks Rank #24 (Strong Sell) List on January 2, 2024.
Sentiment: Neutral
Publish Date: 2024-12-27 18:56:14
The latest trading day saw Ardmore Shipping (ASC) settling at $11.99, representing a +0.17% change from its previous close.
Sentiment: Positive
Publish Date: 2024-12-27 10:01:16
Recently, Zacks.com users have been paying close attention to Ardmore Shipping (ASC). This makes it worthwhile to examine what the stock has in store.
Sentiment: Positive
Publish Date: 2024-12-23 04:22:06
Among the tanker companies I have researched so far, Ardmore Shipping is the only player exposed to the chemical market. Another important element that differentiates ASC from other tanker operators is its net cash balance, which represents ~5.0% of its current market capitalization. According to management, Ardmore would generate earnings per share of approximately $1.97 using charter rates of $25,000 per day, which is roughly in line with what was reported in Q3.
Sentiment: Positive
Publish Date: 2024-12-18 08:38:00
In a head-to-head diet-induced obese (DIO) mouse study, ASC47 low dose combination 1 (ASC47, 3 mg/kg, subcutaneous ( SQ ) , once every four weeks plus semaglutide, 30 nmol/kg, SQ, once daily) , demonstrated superior weight loss compared to semaglutide monotherapy (30 nmol/kg, SQ, once daily), showing an average total body weight reduction of 36.2% compared to 23.1%, a 56.7% greater reduction in body weight compared to semaglutide monotherapy. Human equivalent dose of ASC47 low dose 1 (3 mg/kg, SQ, once every four weeks) in mice is estimated to be approximately 20 mg based on the body surface area conversion.
Sentiment: Positive
Publish Date: 2024-12-16 10:01:29
Recently, Zacks.com users have been paying close attention to Ardmore Shipping (ASC). This makes it worthwhile to examine what the stock has in store.
Sentiment: Positive
Publish Date: 2024-12-11 10:30:28
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Sentiment: Positive
Publish Date: 2024-12-03 10:01:32
Ardmore Shipping (ASC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Sentiment: Positive
Publish Date: 2024-11-25 10:31:16
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Sentiment: Positive
Publish Date: 2024-11-22 10:01:34
Recently, Zacks.com users have been paying close attention to Ardmore Shipping (ASC). This makes it worthwhile to examine what the stock has in store.
Sentiment: Negative
Publish Date: 2024-11-20 07:55:00
Stroke-related cardiovascular injury and dysfunction are induced by AIM2 inflammasome activation in the heart, which can be blocked by ZyVersa's IC 100.
Sentiment: Positive
Publish Date: 2024-11-19 02:19:00
The third quarter results were not that bad. Compared to 3Q23, Ardmore realized higher revenue, EBITDA, and EPS. According to the company's estimates, an additional $10,000 per day equals an annual increase of about $2.25 in EPS increase and nearly $100 million in FCF growth. As of November 06, Ardmore holds $47.6 million cash and owes $30.0 million total debt. Its Total Debt-to-Equity ratio is 8.1%.
Sentiment: Positive
Publish Date: 2024-11-19 01:38:17
Ardmore Shipping's strategic advantage lies in its eco-friendly fleet and operational flexibility, enabling it to capitalize on shifting market dynamics between chemical and petroleum products. Q3 results showed double-digit growth in revenue and EPS, along with improved TCE rates and record-low breakeven levels. Ardmore's balance sheet has strengthened, reducing debt from $97 million to $23 million, and rewarding shareholders with consecutive dividend payouts.
Sentiment: Negative
Publish Date: 2024-11-12 06:30:00
-Phase III trial enrolled a total of 480 patients with moderate to severe acne -Topline results expected in the second quarter 2025 HANGZHOU, China , Nov. 12, 2024 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces completion of enrollment of 480 patients for Phase III clinical trial of ASC40 (denifanstat) o nce-daily oral tablet for treatment of moderate to severe acne. The first patient was enrolled on January 24, 2024.
Sentiment: Positive
Publish Date: 2024-11-11 10:02:17
Recently, Zacks.com users have been paying close attention to Ardmore Shipping (ASC). This makes it worthwhile to examine what the stock has in store.
* The sentiment analysis presented is generated through an algorithm and may be subject to inaccuracies. Users are advised to corroborate key information and employ further analytical methods prior to making critical decisions.
Get instant AI-powered professional insights:
💡Generate AI Technical Analysis ReportUnderstand the chart below:
Interpret Technical Indicators
| Indicator | Bullish | Bearish |
|---|---|---|
| Price and EMA ⓘ | Price crosses above EMA | Price crosses below EMA |
| Short-Term vs Long-Term EMA ⓘ | Short EMA crosses above Long EMA | Short EMA crosses below Long EMA |
| Volume ⓘ | Increasing volume during price uptrend | Increasing volume during price downtrend |
| MACD ⓘ | MACD crosses above Signal Line | MACD crosses below Signal Line |
| RSI ⓘ | RSI is below 30 (oversold) and starts to rise above 30 | RSI is above 70 (overbought) and starts to decline below 70 |
| Candlestick Patterns ⓘ | Bullish candlestick patterns | Bearish candlestick patterns |
Copyright © 2024 Sirius Investors
All rights reserved
